Who are Pink Dx's investors?

Pink Dx's investors include BEVC, Blue Venture Funds, Catalio Capital Management, LP, Mountain Group Capital, Sandbox Industries.

How much funding has Pink Dx raised?

Pink Dx has disclosed $17M raised across 1 round.

Where is Pink Dx headquartered?

Pink Dx is headquartered in Indianapolis, US.

Pink Dx

Indianapolis, US · Founded 2022 · Delaware corporation · 37 employees on LinkedIn · 5 known investors

Find your way into Pink Dx

Paths you didn't know you had: your email and LinkedIn already hold routes to the Pink Dx team. We find them for you
2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone

Days of research, done the moment you sign in, with every route ranked by how warm it is.

PinkDx is a diagnostics company developing tests, led by a leadership team spanning scientific, medical, and business functions.

Biotech Digital Health FemTech

Founders & leadership

Richard T. KloosChief Medical OfficerRichard T. Kloos is Chief Medical Officer at PinkDx, a gynecological cancer diagnostics company. He previously served as Executive Medical Director at Veracyte, a molecular diagnostics company, and was a professor at Ohio State University in endocrinology and nuclear medicine, with extensive involvement in thyroid cancer clinical guidelines and over 135 peer-reviewed publications.

Timothy McMeekanCo-Founder, Chief Financial Officer, and Chief Business Officer

Giulia KennedyFounder

Isaac RoBoard MemberPartner at Catalio Capital Management, LP

Risa StackBoard Member2024–2026Co-Founder & Board Member at menlomicro-bg

Eric WangNamed on SEC filing

Bonnie AndersonCo-founder, CEO & ChairExecutive Officer, Director at Veracyte

Tim McMeekanFounder

Board

Joe C Cook, IIIMember Board of DirectorsManaging Director at Mountain Group Capital

Investors · 5

BEVClisted by BEVCSan Francisco

How we know: BEVC's portfolio page · Not right? Tell us

Blue Venture Fundslisted by Blue Venture FundsChicago · $1M – $20M

How we know: Blue Venture Funds's portfolio page · open dataset · 5k.vc investor directory · Not right? Tell us

Catalio Capital Management, LPlisted by Catalio Capital Management, LPNew York

How we know: Catalio Capital Management, LP's portfolio page · Not right? Tell us

Mountain Group Capitallisted by Mountain Group CapitalNashville

How we know: a partner's Signal profile · Not right? Tell us

Sandbox IndustriesreportedChicago

How we know: a partner's Signal profile · Not right? Tell us

Reported raises · per SEC filings

Form D private placements

$17M disclosed across 1 round · 2023

▶$17MraisedOct 2023 · 7 investors · Biotechnology

Rule 506(b)

Officers, directors & promoters on the filing

Timothy McMeekanDirector
Joe C Cook, IIIDirector
Giulia KennedyExecutive Officer
Isaac RoDirector
Risa StackDirector
Eric WangExecutive Officer
Bonnie AndersonExecutive Officer

Offering amount: $40M
Amount sold: $17M
Minimum investment: $245K
First sale: Sep 2023
Incorporated: Corporation, Delaware, 2022
Federal exemptions: 06b

Full filing on SEC EDGAR ↗

Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.

Related companies · 2

CareDxCareDx provides innovative solutions and diagnostic tools for transplant patients throughout their pre- and post-transplant journey to improve outcomes and equity in organ transplantation.

Foresight DiagnosticsForesight Diagnostics develops ultra-sensitive molecular diagnostic tests that combine genomics and bioinformatics to detect minimal residual disease and circulating tumor DNA across multiple cancer types. Its offerings support oncology drug development, clinical trials, and patient care for academic and biopharma partners.

Companies working in the same space as Pink Dx.

In the news

Pinkdx Raises $40M in Series A Fundingfinsmes.com · Apr 2024

Frequently asked questions

What does Pink Dx do?: PinkDx is a diagnostics company developing tests, led by a leadership team spanning scientific, medical, and business functions.
Who are Pink Dx's investors?: Pink Dx's investors include BEVC, Blue Venture Funds, Catalio Capital Management, LP, Mountain Group Capital, Sandbox Industries.
How much funding has Pink Dx raised?: Pink Dx has disclosed $17M raised across 1 round.
Where is Pink Dx headquartered?: Pink Dx is headquartered in Indianapolis, US.